We often say, "Where patients are, HCPs are."
Only by quickly finding representative physicians with large patient groups and delivering new and correct treatment concepts to them can more patients benefit. To achieve this, companies must first understand an HCP's patient potential. But patient potential is like encrypted text. To decode it, you need the cipher book: HCP data.
In traditional operations, for various reasons, this cipher book was difficult to obtain and not easy to match directly with the encrypted text. This undoubtedly increased the difficulty of hospital procurement. At the same time, the costs pharma companies incurred while decoding the data increased operational pressure to some extent, and some costs could even be passed on to patients. What pharma companies least want to see is that large patient groups cannot access new and correct treatment methods.
Against this background, MeDomino used external public HCP data to build a systematic model, helping a pharma marketing team quickly enable HCPs with high patient potential to understand the latest treatment concepts and help more patients. This can improve treatment outcomes for large patient groups, reduce patient diagnosis and treatment costs, help pharma companies lower operating costs, and bring a new transformation to healthcare.
01 What Is External HCP Data?
- From patients, back to patients.
We live in an internet world full of big data. Anyone can see scattered points of external public data, but few can view the full picture, much less use it effectively. External public HCP data is especially valuable. It contains exploration and reflection on diseases and patients, as well as years of experience and knowledge accumulated by physicians.
In addition to using basic factual HCP data to understand patient potential, companies should also dig deeply into research achievements, academic accomplishments, conference exchanges, and other information to infer patient potential comprehensively and three-dimensionally, so they can better serve large patient groups. MeDomino hopes to serve as a bridge that understands valuable external data, feeds it back to physicians and patients, and ultimately helps patients receive better treatment and care.
02 Advantages: External Data Breaks Through Data Accessibility Limits
This may sound simple, but in past operations, many people did not truly use external data and instead looked for another type of data support. Although that data has advantages, in most cases it has low accessibility, high acquisition difficulty, and high cost. In addition, due to data desensitization and other factors, it usually only reaches the department level, and data from many key hospitals cannot be obtained.
By comparison, external HCP data has clear advantages:
1. External data is relatively easy to obtain.
2. External data is relatively more real time.
3. Costs are relatively lower.
4. It can break through data accessibility limits.
As a result, life sciences companies no longer need to spend large amounts of money and resources to obtain this part of the data. Instead, they can use lower costs to obtain higher-value external data and insights. This solves the challenge of understanding individual HCP patient potential and allows more resources to be invested in improving treatment outcomes, bringing patients a better healthcare experience.
03 Practice: A Data-Validated Model Reveals Hidden Potential
MeDomino's model does not remain at the theoretical level. It is continuously optimized in practice to ensure accurate estimation of HCP potential, and it has been validated through implemented projects.
In our cooperation with the pharma marketing team, comparison with real-world conditions showed that our model had excellent accuracy and reliability. However, because project data is confidential, it cannot be displayed here. Life sciences companies interested in deeper discussion can contact us.
04 Preview: Uncovering the Mystery of HCP Potential
External HCP data covers many dimensions, just like common real-life scenarios:
- When patients choose a hospital, they look at its scale, grade, and transportation convenience.
- When patients choose an HCP, they look at the HCP's profile.
- When patients do not want to go to a hospital for diagnosis, they may communicate with HCPs through online consultations.
Similarly, an HCP potential model should cover many dimensions:
- From the hospital system, we can understand the upper limit of the patient volume an HCP can receive.
- From the HCP themselves, we can understand the disease focus of the patients they receive.
MeDomino's model can also measure HCP academic influence. For example, we can identify HCPs with outstanding research achievements, who can bring hope to more patients. Efficient use of external data, combined with multidimensional comprehensive analysis, helps life sciences companies understand HCP patient potential, customize low-cost personalized operation plans and promotion strategies for HCPs, improve operational efficiency, and benefit more patients.
In summary, external HCP data reveals the mystery of physicians' patient potential, makes physician value visible, and makes the path to patient recovery clearer.
